type stringclasses 2
values | gt_table stringlengths 116 12.6k | image imagewidth (px) 109 761 |
|---|---|---|
simple | <table><tr><td>First author</td><td>Year</td><td>Skin condition</td></tr><tr><td>Praveenkumar et al. [29]</td><td>2016</td><td>Psoriasis</td></tr><tr><td>Kokpol et al. [30]</td><td>2014</td><td>Psoriasis</td></tr><tr><td>Henseler et al. [31]</td><td>1995</td><td>Psoriasis</td></tr><tr><td>Owczarczyk-Saczonek et al. [34... | |
simple | <table><tr><td>MIGS ID</td><td>Property</td><td>Term</td><td>Evidence code<sup>a</sup></td></tr><tr><td></td><td></td><td>Domain <i>Bacteria</i></td><td>TAS [13]</td></tr><tr><td></td><td></td><td>Phylum <i>Bacteroidetes</i></td><td>TAS [14,15]</td></tr><tr><td></td><td></td><td>Class <i>Bacteroidia</i></td><td>TAS [14... | |
complex | <table><tr><td> </td><td>Correct reactions</td><td>Correct</td></tr><tr><td> </td><td>(ignoring enzyme)</td><td>(including enzyme)</td></tr><tr><td colspan="3"><i>Pantothenate and coenzyme A biosynthesis pathway</i></td></tr><tr><td>Recall(P) (%)</td><td>78 (7/9)</td><td>56 (5/9)</td></tr><tr><td>Precision (%)</td><td>... | |
complex | <table><tr><td rowspan="2">Prognosis</td><td rowspan="2">Wald</td><td rowspan="2"><i>P</i></td><td rowspan="2">Exp(B)</td><td colspan="2">95% CI for Exp(B)</td></tr><tr><td>Lower</td><td>Upper</td></tr><tr><td colspan="6">OS</td></tr><tr><td> Age(year) ≥50 vs.<50</td><td>1.577</td><td>0.215</td><td>1.643</td><... | |
simple | <table><tr><td>Year</td><td>Zonal Population*</td><td>New PTB+ cases Reported (n = 8558)</td><td>Case Notification/ 10<sup>5 </sup>persons/year</td><td>Proportion of estimated PTB+ incident cases notified, %**</td></tr><tr><td>1994</td><td>1004000</td><td>512</td><td>49</td><td>45.2</td></tr><tr><td>1995</td><td>107016... | |
complex | <table><tr><td rowspan="3"></td><td colspan="2">Intervention (n=5297)</td><td colspan="2">Control (n=5246)</td><td rowspan="2">Incidence rate ratio (95% CI)</td><td rowspan="2">p value</td></tr><tr><td>Number of events</td><td>Incidence rate (cases per 100 child-years, 95% CI)</td><td>Number of events</td><td>Incidence... | |
simple | <table><tr><td>Folates</td><td>Methionine cycle</td><td>Transsulfuration</td><td>Other</td></tr><tr><td>THF = 4.61</td><td>Met = 49.2</td><td>Cysta = 36.9</td><td>Ser = 563</td></tr><tr><td>510CH = 0.28</td><td>SAM = 81.1</td><td>Cys = 195</td><td>Gly = 924</td></tr><tr><td>510CH2 = 0.51</td><td>SAH = 19.1</td><td>GluC... | |
complex | <table><tr><td>Physical symptoms</td><td colspan="4">GSF group</td><td colspan="4">Non-GSF group</td><td> </td></tr><tr><td>Subscale and item</td><td>Very much</td><td>Quite a bit</td><td>A little bit</td><td>Not at all</td><td>Very much</td><td>Quite a bit</td><td>A little bit</td><td>Not at all</td><td>Missing</td></... | |
complex | <table><tr><td>Experimental phase</td><td>Correlation</td><td>Brain regions</td><td>x</td><td>y</td><td>z</td><td>Cluster size</td><td>t value</td><td><i>p</i> value FWE</td></tr><tr><td rowspan="7">Fear conditioning</td><td rowspan="5">Positive</td><td>Posterior cingulate cortex</td><td>12</td><td>−34</td><td>46... | |
complex | <table><tr><td> </td><td colspan="2">ANXA1-SER</td><td> </td><td colspan="2">ANXA1-TYR</td><td> </td></tr><tr><td> </td><td>HPV+</td><td>HPV-</td><td>Controls</td><td>HPV+</td><td>HPV-</td><td>Controls</td></tr><tr><td>Cancer</td><td>13.5 ± 1.6</td><td>14.6 ± 0.4</td><td>-</td><td>15.3 ± 0.6**</td><td>13... | |
complex | <table><tr><td>Variations</td><td></td><td>1<sup>st</sup> Day</td><td>2<sup>nd</sup> Day</td><td>3<sup>rd</sup> Day </td><td>P value</td></tr><tr><td rowspan="2">Number of bolusesrequired</td><td>Group B</td><td>31.47±24.39</td><td>24.07±20.25</td><td>19.20±14.59</td><td rowspan="2">0.084</td></tr><tr><t... | |
complex | <table><tr><td>Components</td><td>Mean IOP (±SD)</td><td>P Value</td><td>Mean CCT (±SD)</td><td>P Value</td></tr><tr><td colspan="5">Abdominal Obesity</td></tr><tr><td>Yes</td><td>26.23±4.17</td><td>0.126</td><td>591.12±56.15</td><td>0.317</td></tr><tr><td>No </td><td>25.34±3.76</td><td> </td><... | |
simple | <table><tr><td>Reference</td><td>Measurement of PAH-RPF/true RPF (<i>n</i>/<i>n</i>)</td><td>PAH-RPF (ml/min)</td><td>True RPF (ml/min)</td></tr><tr><td>[17]</td><td>6 (0)</td><td>-</td><td>690</td></tr><tr><td>[18]</td><td>40 (11)</td><td>475</td><td>1116</td></tr><tr><td>[19]</td><td>22 (6)</td><td>474</td><td>1238</... | |
simple | <table><tr><td>SNP</td><td>MAF (% [<i>n</i>/<i>N</i>])</td><td>OR (95% CI)</td><td><i>P</i></td></tr><tr><td>rs600144</td><td></td><td></td><td></td></tr><tr><td> Cases</td><td>25.9 (850/3278)</td><td>0.96 (0.9 to 1.1)</td><td>NS</td></tr><tr><td> Controls</td><td>26.8 (857/3202)</td><td></td><td></td></tr><tr><td>rs11... | |
simple | <table><tr><td></td><td>accepted marine species in WORMS</td><td>18S V9 OTUs in plankton<sup>a</sup></td></tr><tr><td>Acanthocephala</td><td>468</td><td>0</td></tr><tr><td>Annelida</td><td>12 862</td><td>404 (48)</td></tr><tr><td>Arthropoda</td><td>57 871</td><td>9497 (205)</td></tr><tr><td>Brachiopoda</td><td>396</td>... | |
complex | <table><tr><td></td><td>CON</td><td>HSD2BKO</td></tr><tr><td>Adrenal size: body weight (adult)</td><td>5.9 ± 0.9 × 10<sup>−4</sup> (15)</td><td>4.9 ± 0.9 × 10<sup>−4</sup> (18)</td></tr><tr><td colspan="3">

</td></tr><tr><td colspan="3">Brain gene expression (<i>n</i> = 5... | |
simple | <table><tr><td>Level of lesion</td><td>Number of patients</td><td>Percentage</td></tr><tr><td>Thoracic</td><td>3</td><td>3.49</td></tr><tr><td>Thoracolumbar</td><td>6</td><td>6.98</td></tr><tr><td>Lumbar</td><td>23</td><td>26.74</td></tr><tr><td>Lumbosacral</td><td>18</td><td>20.93</td></tr><tr><td>Sacral</td><td>16</t... | |
simple | <table><tr><td></td><td>β</td><td>t</td><td><i>p</i></td></tr><tr><td>Maternal age (per year)</td><td>−0.008</td><td>−0.45</td><td>0.65</td></tr><tr><td>Maternal weight (per kg)</td><td>0.211</td><td>11.77</td><td><0.001</td></tr><tr><td>Frozen thawed embryo (versus fresh embryo)</td><td>0.079</td><... | |
complex | <table><tr><td></td><td colspan="2">Secretory uric acid transporter</td></tr><tr><td>Compound</td><td>OAT1</td><td>ABCG2</td></tr><tr><td>Lesinurad</td><td>3.90 ± 0.94</td><td>>100</td></tr></table> | |
simple | <table><tr><td>Pathway</td><td>Description</td></tr><tr><td>G protein-coupled receptor (GPCR) signaling</td><td>There are more than 800 GPR genes in the genome. These receptors activate adenyl cyclase to produce cAMP from ATP, or in the phosphatidylinositol pathway to produce a cell response, depending on the context. ... | |
complex | <table><tr><td>Characteristic</td><td>Case (<i>n</i> = 82)</td></tr><tr><td colspan="2">Age in years</td></tr><tr><td>> 45</td><td>21</td></tr><tr><td>≤ 45</td><td>61</td></tr><tr><td colspan="2">Sex</td></tr><tr><td> Male</td><td>33</td></tr><tr><td> Female</td><td>49</td></tr><tr><td>Tumour size, cm</td><td>... | |
complex | <table><tr><td>Annual Report Year</td><td>Case Number</td><td>Clinical Summary</td></tr><tr><td colspan="3">Patients Treated with FabAV</td></tr><tr><td>2001</td><td>55</td><td>A 17-year-old girl presented after apparent intravascular envenomation by an unknown snake with features of anaphylaxis to venom. Within minute... | |
complex | <table><tr><td rowspan="2">Groups</td><td rowspan="2">Dose (mg/Kg bw)</td><td colspan="3">Blood antioxidant enzymes</td></tr><tr><td>SOD (U/g Hb)</td><td>GPX (U/g Hb)</td><td>CAT (K/g Hb)</td></tr><tr><td>NC</td><td>-</td><td>2943 ± 104.4 <sup>a</sup></td><td>51.31±4.2<sup>a</sup></td><td>1.57 ± 0.6<sup>... | |
simple | <table><tr><td></td><td>NanoString FROZ vs FFPE</td><td>ScriptSeq FROZ vs FFPE</td></tr><tr><td>BRB123</td><td>0.926 (0.950)</td><td>0.790 (0.943)</td></tr><tr><td>BRB144</td><td>0.955 (0.965)</td><td>0.807 (0.957)</td></tr><tr><td>BRB147</td><td>0.728 (0.917)</td><td>0.802 (0.945)</td></tr><tr><td>BRB157</td><td>0.807... | |
simple | <table><tr><td></td><td><i>N</i></td><td>Drug</td><td>Duration</td><td>Subcutaneous adipose tissue</td><td>Visceral adipose tissue</td><td>Body mass index (kg/m<sup>2</sup>)</td><td>Reference</td></tr><tr><td>No change in SAT</td><td>30</td><td>Rosi versus placebo</td><td>24 weeks</td><td>MRI: NS</td><td>MRI: NS</td><t... | |
simple | <table><tr><td></td><td>Group A (non-GBA)</td><td>Group B (GBA)</td><td><i>P</i> value</td></tr><tr><td>Neck lymphadenopathy</td><td>26/60 (43%)</td><td>7/14 (50%)</td><td>NS</td></tr><tr><td>Fissured lips</td><td>53/60 (88%)</td><td>12/14 (86%)</td><td>NS</td></tr><tr><td>Strawberry tongue</td><td>47/61 (77%)</td><td>... | |
simple | <table><tr><td>Heuristic</td><td>Network load (No. of groups)</td><td>Channel Constraint (<i>ω</i>)</td><td>Radio Constraint</td><td>Network Size</td><td>Communication Radius</td></tr><tr><td>SPT</td><td>(200%, 200%)*</td><td>(175%, 150%)</td><td>(400%, 350%)</td><td>(300%, 142%)</td><td>(180%, 175%)</td></tr><tr>... | |
simple | <table><tr><td>AMPLICON</td><td>SSCP ANALYSIS</td><td>HRMA/SEQUENCING<sup>1</sup></td><td>N. OF CASES</td></tr><tr><td>EXON 1</td><td>WT</td><td>WT</td><td>26</td></tr><tr><td>EXON 2</td><td>WT</td><td>WT</td><td>23</td></tr><tr><td></td><td>WT</td><td>c.[64G > A]+[=]</td><td>1</td></tr><tr><td></td><td>c.[64G > ... | |
complex | <table><tr><td rowspan="2">Essential oil</td><td colspan="2"><i>S. pyogenes</i></td><td colspan="2"><i>S. pneumoniae</i></td><td colspan="2"><i>S. mutans</i></td></tr><tr><td>MIC</td><td>MBC</td><td>MIC</td><td>MBC</td><td>MIC</td><td>MBC</td></tr><tr><td>Cinnamon bark</td><td>0.41</td><td>0.81</td><td>0.06</td><td>0.1... | |
complex | <table><tr><td>Stimulus 1</td><td>Stimulus 2</td><td>95% CI Lower bound</td><td>Difference of Means (1–2)</td><td>95% CI Upper bound</td><td><i>P</i></td></tr><tr><td colspan="6">TOTALLY ENGAGED (<i>N</i> = 27)</td></tr><tr><td>Audio only</td><td>Multimodal</td><td>–39.72</td><td>–28.33</td><td>–... | |
complex | <table><tr><td>Activities Related to HAI Prevention</td><td>Professional Groups</td><td><i>N</i></td><td>Average Values in Groups</td><td>Median</td><td>Standard Deviation</td><td>95% CI</td></tr><tr><td rowspan="3">Hand-hygiene</td><td>Medical student</td><td>28</td><td>5.6</td><td>6.0</td><td>2.71</td><td>4.649, 6.49... | |
complex | <table><tr><td></td><td colspan="4">urine pH > 5.5 (idRTA)</td><td colspan="4">urine pH < 5.5</td><td>p</td></tr><tr><td></td><td>Baseline</td><td>3 months</td><td>6 months</td><td>9 months</td><td>Baseline</td><td>3 months</td><td>6 months</td><td>9 months</td><td></td></tr><tr><td>serum alkaline phosphate (U/L)... | |
simple | <table><tr><td>Identified Motif Sequence</td><td># Seqs withMotif</td><td>Motif E-Value</td><td>TRANS FAC Hit ID</td><td>TRANS AC Binding Site Sequence</td><td>TRANS FAC annotation</td></tr><tr><td>CATCCAACGGC</td><td>29</td><td>1.2E-1</td><td>M00227</td><td>TCCAACGGC</td><td>Myb</td></tr><tr><td>CCCGCCACGCGCCAC</td><t... | |
simple | <table><tr><td></td><td>Number</td><td>Percentage (%)</td></tr><tr><td>1 year follow up</td><td>66</td><td>81.5</td></tr><tr><td>Lost to follow up</td><td>5</td><td>6</td></tr><tr><td>Deceased at 1 year</td><td>10</td><td>12.3</td></tr><tr><td>Referral done to specialized cardiology center</td><td>37</td><td>45.6</td><... | |
simple | <table><tr><td>Modification</td><td>Hypotheses tested</td></tr><tr><td>Ranking task</td><td>Introducing the ranking task prior to the cTTO valuation will reduce the inconsistencies and improves the overall data quality (i.e. more WTD responses).</td></tr><tr><td>BTD/WTD split</td><td>Separating the BTD and WTD cTTO tas... | |
simple | <table><tr><td>Viroid small RNAs (vd-sRNAs)</td><td>Reference</td></tr><tr><td>vd-sRNAs of peach latent mosaic viroid were used to study the viroid evolution and pathogenesis</td><td>Di Serio et al., 2009; Navarro et al., 2012a</td></tr><tr><td>Gaining further insights into the genesis and role of vd-RNAs of hop stunt ... | |
complex | <table><tr><td rowspan="2">Species</td><td rowspan="2">Specimen voucher</td><td colspan="4"><i>cox</i>1<sup><i>a</i></sup></td><td colspan="4">ITS-2<sup>b</sup></td></tr><tr><td>GenBank accession no.</td><td>Length (bp)</td><td>G+C content (%)</td><td>Pairwise difference (%)</td><td>GenBank accession no.</td><td>Length... | |
complex | <table><tr><td>Parameter</td><td colspan="2">Value</td></tr><tr><td></td><td colspan="2">n = 4068</td></tr><tr><td>Age (n,%)</td><td></td><td></td></tr><tr><td> 18-34</td><td>20</td><td>0.5</td></tr><tr><td> 35-44</td><td>108</td><td>2.7</td></tr><tr><td> 45-54</td><td>513</td><td>12.6</td></tr><tr><td> 55-64</td><td>1... | |
complex | <table><tr><td>Combination</td><td colspan="3">Nr of MRSA strains (%) for which combinations gave</td></tr><tr><td></td><td>Synergy</td><td>No interaction</td><td>Antagonism</td></tr><tr><td>LVX + VA (n = 50)</td><td>16 (32)</td><td>34 (68)</td><td>0</td></tr><tr><td>LVX + TEC (n = 50)</td><td>9 (18)</td><td>41 (82)</t... | |
complex | <table><tr><td></td><td>Attack-free periods Mean ± S.D.</td><td>Control Mean ± S.D.</td><td>P</td></tr><tr><td>IOP, mmHg</td><td><i>14,11 ± 2,88</i></td><td>15,81 ± 0,81</td><td rowspan="2">0,07</td></tr><tr><td>Range</td><td>(11–20)</td><td>(11–20)</td></tr><tr><td>AL, mm</td><td>23,08 ... | |
simple | <table><tr><td>Gene</td><td>Number of exons</td><td>Number of mutations worldwide**</td><td>Number of homopolymer repeats* in CDS</td><td>Function in hearing process</td></tr><tr><td><i>GJB2</i></td><td>2</td><td>> 220</td><td>0</td><td>ion homeostasis</td></tr><tr><td><i>SLC26A4</i></td><td>21</td><td>43</td><td>7<... | |
complex | <table><tr><td rowspan="3">Parameter</td><td colspan="6">Mean value for group ± SE<sup><i>a</i></sup></td></tr><tr><td rowspan="2">NI</td><td rowspan="2">Pretherapy (120 dpi)</td><td colspan="4">Posttherapy (180–200 dpi)</td></tr><tr><td>Veh</td><td>PTX</td><td>Bz</td><td>Bz+PTX</td></tr><tr><td>Parasitemia ... | |
complex | <table><tr><td rowspan="2">Parameter</td><td colspan="3">Temperature (K)</td></tr><tr><td>293 </td><td>303 </td><td>313 </td></tr><tr><td>−Δ<i>G</i>° (kJ mol<sup>−1</sup>)</td><td>6.543</td><td>6.063</td><td>5.687</td></tr><tr><td>−Δ<i>H</i>° (kJ mol<sup>−1</sup>)</td><td>16.... | |
simple | <table><tr><td>Temperature (°C)</td><td>−40</td><td>−20</td><td>0</td><td>+20</td><td>+40</td><td>+60</td></tr><tr><td>Resonant frequency of the upper resonator (Hz)</td><td>31,331.12</td><td>31,379.3</td><td>31,426.16</td><td>31,462.37</td><td>31,496.56</td><td>31,514.02</td></tr><tr><td>Resonant freq... | |
simple | <table><tr><td>Participant code</td><td>Sex</td><td>Age (yrs)</td><td>BMI (kg/m<sup>2</sup>)</td><td>Injury level and AIS score</td><td>Years since SCI</td><td>Medications</td><td>Treatment</td></tr><tr><td>1</td><td>M</td><td>46</td><td>32.9</td><td>C5A</td><td>23.3</td><td>Baclofen, Temazepam</td><td>CPAP</td></tr><t... | |
complex | <table><tr><td> </td><td> </td><td colspan="2">Women</td><td colspan="2">Men</td></tr><tr><td> </td><td> </td><td colspan="2">N = 214</td><td colspan="2">N = 154</td></tr><tr><td> </td><td> </td><td>OR</td><td>p</td><td>OR</td><td>p</td></tr><tr><td>Surgical specialties</td><td>Combining work with family</td><td>0.4 (0... | |
simple | <table><tr><td>Characteristics</td><td>THC score mean (SE)</td><td>CH score mean (SE)</td><td>PH score mean (SE)</td><td><i>P</i> value</td></tr><tr><td>First contact and continuity</td><td>95.40 (0.39)</td><td>90.93 (0.52)</td><td>85.23 (0.51)</td><td><0.001</td></tr><tr><td>Comprehensiveness (medical care)</td><td... | |
complex | <table><tr><td>Authors</td><td>Intervention</td><td>Patient Population</td><td>Design</td><td>No. of Patients</td><td>Outcome</td></tr><tr><td rowspan="2">Pizzocarro et al<sup>15</sup></td><td rowspan="2">IFN-α2b <i>v</i> placebo</td><td rowspan="2">Robson stages II and III (T3aN0M0 and T3bN0M0 or T2/3N1-3M0)</td>... | |
simple | <table><tr><td>Species</td><td>Fu’s <i>FS</i></td><td>Tajima’s <i>D</i></td><td>SSD</td><td><i>rg</i></td></tr><tr><td><i>H. bovis</i></td><td>−12.795***</td><td>−2.031 **</td><td>0.001</td><td>0.035</td></tr><tr><td><i>H. sinense</i></td><td>−19.809***</td><td>−2.320**</td><td>0.001... | |
simple | <table><tr><td>Primary</td><td>Definition</td></tr><tr><td>Tumor (T)</td><td></td></tr><tr><td>Tx</td><td>Primary tumor cannot be assessed</td></tr><tr><td>T0</td><td>No evidence of primary tumor</td></tr><tr><td>Tis</td><td>Carcinoma in situ</td></tr><tr><td>T1</td><td>Tumor 2 cm or less in greatest dimension and no m... | |
simple | <table><tr><td>Location of study village</td><td>Types of prevention practices reported</td><td>Frequency & motivation for bed net use</td><td>Influences on preventative health behaviours</td><td>Community suggestions for participation in malaria elimination</td></tr><tr><td>North Tanna</td><td>Use of bed netsClean... | |
complex | <table><tr><td rowspan="3">Sex and variable</td><td colspan="4">Blood pressure category</td><td rowspan="3"><i>P</i> for difference<sup>b</sup></td></tr><tr><td>Normal</td><td>Pre-</td><td>Stage 1</td><td>Stage 2<sup>a</sup></td></tr><tr><td>Men</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> No. of... | |
complex | <table><tr><td>Exon</td><td>Primers (3′-5′)</td><td>Annealing temperature (°C)</td><td>Buffer pH</td><td>MgCl<sub>2</sub> (mM)</td><td>% DMSO</td><td>Fragment (bp)</td></tr><tr><td rowspan="2">1</td><td>F: GCAGATTTAAAGCAACACCACC</td><td rowspan="2">60</td><td rowspan="2">8.4</td><td rowspan="2">1</td><... | |
complex | <table><tr><td></td><td colspan="7"><i>r</i>/<i>P</i></td></tr><tr><td></td><td>sIL-6</td><td>sVEGF</td><td>pVEGF</td><td>D-D</td><td>Platelets</td><td>Fibrinogen</td><td>sVEGF/pl</td></tr><tr><td>sIL-6</td><td></td><td>0.25/0.03</td><td>0.33/0.005</td><td>0.41/0.006</td><td></td><td>0.23/0.06</td><td>0.22/0.06</td></t... | |
complex | <table><tr><td colspan="2">Variable</td><td colspan="2">CTX only</td><td colspan="2">Trastuzumab + CTX</td><td colspan="2">Total</td><td><i>P</i>-value</td></tr><tr><td colspan="2">Number of patients</td><td colspan="2">45</td><td colspan="2">70</td><td colspan="2">115</td><td></td></tr><tr><td colspan="2">Gender</td><... | |
simple | <table><tr><td>Factors</td><td>β</td><td>S.E.</td><td>aOR (95% CI)</td></tr><tr><td>Residence (rural vs. urban)</td><td>0.79</td><td>0.36</td><td>2.03 (1.30–4.25)</td></tr><tr><td>Parental history of T1DM (positive history vs. negative)</td><td>3.90</td><td>2.54</td><td>9.03 (1.02–85.32)</td></tr><tr><... | |
simple | <table><tr><td>Sample sizes</td><td>N</td><td>Alternative</td><td>Power</td><td>Correct classif. rate</td></tr><tr><td>200/200/200/200</td><td>800</td><td>.05/.05/.05/.10</td><td>.682</td><td>.935</td></tr><tr><td>540/200/40/20</td><td>800</td><td>.05/.05/.05/.10</td><td><i>.251</i></td><td>.758</td></tr><tr><td>200/20... | |
simple | <table><tr><td>Substance</td><td>Reported Usage</td><td>Percent of Survey Participants</td></tr><tr><td>Opioid Pharmaceuticals</td><td>18</td><td>5.95%</td></tr><tr><td>Hallucinogens</td><td>11</td><td>3.63%</td></tr><tr><td>MDMA/Ecstasy</td><td>10</td><td>3.30%</td></tr><tr><td>Cocaine/Crack Cocaine</td><td>7</td><td>... | |
complex | <table><tr><td>Variables</td><td>Lean</td><td>Overweight</td><td>Obese</td><td><i>p</i> for heterogeneity</td></tr><tr><td>BMI (kg/m<sup>2</sup>)(mean)</td><td>18.5–24.9922.7 ± 1.7</td><td>25–29.9927.1 ± 1.6</td><td>≥3033.5 ± 3.8</td><td></td></tr><tr><td>No. of subjects (%)</td><td>246... | |
simple | <table><tr><td>Time since quitting</td><td>Beneficial health changes that take place</td></tr><tr><td>24 h</td><td>Lungs start to clear out mucus and other smoking debris</td></tr><tr><td>48 h</td><td>Carbon monoxide will be eliminated from the body. Ability to taste and smell is greatly improved</td></tr><tr><td>72 h<... | |
simple | <table><tr><td><i>Characteristic</i></td><td><i>N</i></td><td><i>%</i></td></tr><tr><td>Pre-pregnancy nutritional status (BMI)</td><td></td><td></td></tr><tr><td>Underweight (<18.5 kg/m<sup>2</sup>)</td><td>84</td><td>10.9</td></tr><tr><td>Normal weight (18.5 – 24.99 kg/m<sup>2</sup>)</td><td>494</td><td>63.8<... | |
simple | <table><tr><td>Analysis</td><td>Number of plants assayed</td><td>Number of tolerant plants</td><td>Transformation frequency</td></tr><tr><td>Basta leaf paint</td><td>78</td><td>70</td><td>89.73%</td></tr><tr><td>Kanamycin/paromomycin Leaf bleach</td><td>34</td><td>32</td><td>94.12%</td></tr></table> | |
simple | <table><tr><td>Plant specie</td><td> Aa length</td><td>PTS1</td><td>pI</td><td>Molecular Mass (kDa)</td><td>Accession number</td></tr><tr><td><i>Arabidopsis thaliana</i></td><td>486</td><td>-SKI</td><td>7.02 </td><td>53.6</td><td>AEE73797.1</td></tr><tr><td><i>Cleome spinosa</i></td><td>485</td><td>-SMI</td><td>5.80</t... | |
complex | <table><tr><td>Oil</td><td>Isothermal T (°C)</td><td>t<sub>0</sub> (min)</td><td>t<sub>max</sub>(min)</td><td>Regression equation<sub>a</sub></td><td>R<sup>2</sup><sub>b</sub></td><td>Reported t<sub>0</sub> or shelf life at 20 °C (d)</td></tr><tr><td colspan="7">Linola</td></tr><tr><td></td><td>100</td><td>17... | |
simple | <table><tr><td>Resource</td><td>Brief description</td><td>Included information</td></tr><tr><td>Facilitator manual</td><td>Comprehensive train-the-trainer manual detailing all information required for the delivery of the program</td><td>* Introduction* Successful facilitating* Background to the research* Session guides... | |
simple | <table><tr><td></td><td>F0-1</td><td>F2-4</td><td>P value</td><td>F0-2</td><td>F3-4</td><td>P value</td><td>F0-3</td><td>F4</td><td>P value</td></tr><tr><td>HBeAg (+)</td><td>4.60 (4.38-4.78)</td><td>4.12 (3.98-4.30)</td><td><0.001</td><td>4.51 (4.28-4.74)</td><td>4.03 (3.89-4.25)</td><td><0.001</td><td>4.48 (4.2... | |
complex | <table><tr><td></td><td></td><td colspan="3">Echium Oil</td><td colspan="3">Fish Oil</td><td colspan="3">Significant Effect</td></tr><tr><td>Fatty Acids</td><td>Control</td><td>EO-1</td><td>EO-3</td><td>EO-5</td><td>FO-1</td><td>FO-3</td><td>FO-5</td><td>Oil</td><td>Dose</td><td>Oil × Dose</td></tr><tr><td>C16:0</... | |
complex | <table><tr><td rowspan="2">Stimulus/Cytokine</td><td>Model 1</td><td>Model 2</td><td>Model 3</td></tr><tr><td>OR (95%CI)</td><td>OR (95%CI)</td><td>OR (95%CI)</td></tr><tr><td>Spontaneous production</td><td></td><td></td><td></td></tr><tr><td> IL-5 (n = 418)</td><td>1.42 (0.93;2.15)</td><td>1.00 (0.52;1.92)</td><td>0.9... | |
complex | <table><tr><td> </td><td>Kindergarten</td><td>Elementary school</td><td>Junior high school</td><td rowspan="3"><i>P</i>-value<sup>b</sup></td></tr><tr><td> </td><td><i>n</i> (%)</td><td><i>n</i> (%)</td><td><i>n</i> (%)</td></tr><tr><td colspan="4">Feeling upon awakening</td><td> </td></tr><tr><td> good</td><td>213 (86... | |
complex | <table><tr><td>Instrument</td><td>Countries</td></tr><tr><td colspan="2">Supply side regulation: in patent drugs</td></tr><tr><td>Price controls: administrative or statutory pricing</td><td>All EU Member States except Germany, UK and, to a certain extent, Sweden</td></tr><tr><td>External reference pricing</td><td>All E... | |
complex | <table><tr><td> </td><td colspan="3">Baseline</td><td colspan="3">12 months</td><td colspan="3">18 months</td></tr><tr><td> </td><td>W</td><td>WB</td><td>C</td><td>W</td><td>WB</td><td>C</td><td>W</td><td>WB</td><td>C</td></tr><tr><td> </td><td>N</td><td>N</td><td>N</td><td>N</td><td>N</td><td>N</td><td>N</td><td>N</td... | |
complex | <table><tr><td></td><td></td><td colspan="4">Male</td><td colspan="4">Female</td></tr><tr><td></td><td></td><td colspan="2">CCU or ICU</td><td colspan="2">Medical ward</td><td colspan="2">CCU or ICU</td><td colspan="2">Medical ward</td></tr><tr><td>Age groups</td><td>Standard Population</td><td>Death rate %</td><td>Exp... | |
simple | <table><tr><td>ATC Code</td><td>Drug classification</td><td>No. of visits </td><td>%</td></tr><tr><td>G01A</td><td>Anti-infectives</td><td>5402</td><td>15.1%</td></tr><tr><td>M01A</td><td>Anti-inflammatory, non-steroids</td><td>3754 </td><td>10.5%</td></tr><tr><td>N02B</td><td>Other analgesics and anti-pyretics</td><td... | |
simple | <table><tr><td>Variables</td><td>Number</td><td>Percentage </td></tr><tr><td>Acute or chronic inflammation</td><td>36</td><td>30</td></tr><tr><td>Rheumatism </td><td>33</td><td>26.6</td></tr><tr><td>Degeneration of valves</td><td>49</td><td>40.8</td></tr><tr><td>Endocarditic </td><td>2</td><td>1.6</td></tr></table> | |
complex | <table><tr><td></td><td></td><td colspan="3">Pairwise correlation at age 7 year</td></tr><tr><td>Compound</td><td>PFAS concentration, ng/mL, median (IQR<sup>a</sup>)</td><td>PFOS</td><td>PFOA</td><td>PFHxS</td></tr><tr><td>Age 5 year</td><td></td><td></td><td></td><td></td></tr><tr><td>PFOS</td><td>17.3 (14.2,21.3)</td... | |
simple | <table><tr><td>Analyses</td><td>Nanoemulsion</td><td>Curcumin-nanoemulsion</td></tr><tr><td>Size (nm)</td><td>200 ± 9.9</td><td>199 ± 0.2</td></tr><tr><td>Zeta potential (mV)</td><td>−40.2</td><td>−46.3</td></tr><tr><td>Polydispersity index (PdI)</td><td>0.248</td><td>0.179</td></tr></table> | |
simple | <table><tr><td></td><td>BMD (g/cm<sup>2)</sup></td><td>BMC (g)</td><td>Area (cm<sup>2)</sup></td></tr><tr><td>Lumbar Vertebra</td><td></td><td></td><td></td></tr><tr><td> Baseline (n = 8)</td><td>0.237 ± 0.018</td><td>0.502 ± 0.073</td><td>2.124 ± 0.287</td></tr><tr><td> Control (n = 12)</td><td>0.259 &#... | |
simple | <table><tr><td>Indicators</td><td>Value</td></tr><tr><td>White blood cell</td><td>5200/<i>μ</i>L</td></tr><tr><td>Hemoglobin</td><td>11.3 g/dL</td></tr><tr><td>Platelet</td><td>103 × 10<sup>3</sup>/<i>μ</i>L</td></tr><tr><td>Prothrombin time</td><td>96%</td></tr><tr><td>Activated partial thromboplastin t... | |
complex | <table><tr><td>H-reflex parameters</td><td>Ankle Positions</td><td colspan="6">Muscle and posture</td></tr><tr><td></td><td></td><td colspan="2">Sol</td><td colspan="2">MG</td><td colspan="2">LG</td></tr><tr><td></td><td></td><td>Lying</td><td>Standing</td><td>Lying</td><td>Standing</td><td>Lying</td><td>Standing</td><... | |
simple | <table><tr><td>Groups</td><td>LDH</td><td>CK-MB</td><td>CK</td><td>CTN-I</td><td>MB</td></tr><tr><td>C</td><td>0.92 ± 0.04</td><td>2.11 ± 0.18</td><td>11.70 ± 0.46</td><td>144.61 ± 12.71</td><td>3.32 ± 0.49</td></tr><tr><td>EE</td><td>1.08 ± 0.09<sup><i>∗</i></sup></td><td>3.23 ±... | |
complex | <table><tr><td>Genotypes</td><td colspan="3">No. identified proteins</td><td colspan="3">ρ-Value<sup>a</sup>/FPR<sup>b</sup>(%)</td><td>No. proteins</td></tr><tr><td></td><td>Rep#1</td><td>Rep#2</td><td>Rep#3</td><td>Rep#1</td><td>Rep#2</td><td>Rep#3</td><td></td></tr><tr><td>Resistant<sup>c</sup></td><td>3297</td... | |
simple | <table><tr><td>Key actor</td><td>Moura-Barrancos</td><td>Guadiana</td><td>Malcata</td><td>Total</td></tr><tr><td>Land owners (including livestock breeders)</td><td>9</td><td>9</td><td>5</td><td>23</td></tr><tr><td>Local council representatives</td><td>8</td><td>8</td><td>8</td><td>24</td></tr><tr><td>Local nature conse... | |
complex | <table><tr><td> </td><td colspan="2"> Participants</td><td colspan="2">GPS routes</td></tr><tr><td> </td><td>N</td><td>%</td><td>N</td><td>%</td></tr><tr><td>Total/All</td><td>175</td><td> </td><td>1191</td><td> </td></tr><tr><td>Sex</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Girl</td><td>89</td><td>50.8... | |
complex | <table><tr><td rowspan="2">Measurement day</td><td rowspan="2">Dosage</td><td colspan="2">ucOC (ng/mL)</td><td colspan="2">Gla-OC (ng/mL)</td><td colspan="2">UGR</td><td colspan="2">Dietary vitamin K intake (μg/week)</td></tr><tr><td>Median</td><td>Range</td><td>Median</td><td>Range</td><td>Median</td><td>Range</t... | |
simple | <table><tr><td>Topic</td><td>Reference</td><td>Question</td><td>Summary of the results</td></tr><tr><td>Knowledge</td><td>(26–42)</td><td>Differences in knowledge</td><td>Almost all studies found a gradient in knowledge about HPV and cervical cancer with any of the variables used to measure SES or deprivation: ed... | |
simple | <table><tr><td><i>Cytogenetic abnormality</i></td><td><i>Frequency</i></td><td>ASXL1 <i>mutational frequency</i></td><td>SETBP1 <i>mutational frequency</i></td><td>SRSF2 <i>mutational frequency</i></td><td>U2AF1 <i>mutational frequency</i></td><td>SF3B1 <i>mutational frequency</i></td><td><i>Spanish cytogenetic risk st... | |
simple | <table><tr><td>Risk factor</td><td>Changes in capillary morphology or blood rheology</td></tr><tr><td>Aging</td><td>Human brain: Pericyte loss. Variable capillary diameters, increased capillary tortuosity, twisting, and looping. Thickened basement membranes with inclusions. Pericapillary fibrosis [29, 30]</td></tr><tr>... | |
simple | <table><tr><td>Authors</td><td>Contrast</td></tr><tr><td><sup>*</sup>Aichorn et al., 2009</td><td>False belief > photo (question)</td></tr><tr><td><sup>*</sup>Abraham et al., 2010</td><td>Belief-questions > control-questions and desire-questions > control-questions</td></tr><tr><td><sup>*</sup>Bahnemann et al.... | |
complex | <table><tr><td></td><td colspan="2">With seizures<sup>§</sup></td><td></td><td rowspan="2">Without seizures</td></tr><tr><td></td><td>Early seizures</td><td>Late seizures</td><td><i>p</i>value</td></tr><tr><td></td><td>n = 13 (%)</td><td>n = 15 (%)</td><td></td><td>n = 152 (%)</td></tr><tr><td>Mean age, years</td>... | |
complex | <table><tr><td>Scale</td><td>Whole sample</td><td colspan="3">Gender</td><td colspan="3">Presence of symptoms</td></tr><tr><td></td><td>N = 446</td><td>Boys N = 207</td><td>Girls N = 239</td><td>p-value (ANOVA)</td><td>No symptoms N = 197</td><td>At least one symptom once a week N = 199</td><td>p-value (ANOVA)</td></tr... | |
complex | <table><tr><td rowspan="2">Maternal health service use indicator</td><td rowspan="2">Overall (<i>n</i> = 1457)</td><td colspan="2">District</td><td rowspan="2"><i>P</i> value</td></tr><tr><td>Jhelum (<i>n</i> = 747)</td><td>Layyah (<i>n</i> = 710)</td></tr><tr><td>Sought at least one antenatal care (ANC) visit</td><td>... | |
complex | <table><tr><td></td><td>High-energy probe</td><td>Low-energy probe</td><td>Units</td></tr><tr><td>Source used</td><td><sup>22</sup>Na</td><td><sup>99m</sup>Tc</td><td></td></tr><tr><td>Photon energy</td><td>511</td><td>142</td><td>keV</td></tr><tr><td>Sensitivity</td><td>10</td><td>12</td><td>cps/kBq</td></tr><tr><td c... | |
simple | <table><tr><td>Data</td><td>Feature</td><td>Vector</td><td>Algorithm</td><td>F1</td><td>AUC</td><td><i>p</i>-value</td></tr><tr><td>iDASH</td><td>Bag-of-words + UMLS (5SG)</td><td>Tf-idf</td><td>SVM-Lin</td><td>0.932</td><td>0.957</td><td><0.01</td></tr><tr><td></td><td>Bag-of-words + UMLS (All)</td><td>Tf-idf</td><... | |
simple | <table><tr><td>Characteristic</td><td>Number (N = 1,568)</td><td>Percent (%)</td></tr><tr><td>Sex</td><td>915</td><td>58.4</td></tr><tr><td>Female</td><td>653</td><td>41.6</td></tr><tr><td>Male</td><td></td><td></td></tr><tr><td>Age group (in years)</td><td></td><td></td></tr><tr><td>15 – 24</td><td>410</td><td>2... | |
simple | <table><tr><td></td><td>CHF absent (n = 66)</td><td>CHF present (n = 29)</td><td>p</td></tr><tr><td>Age (years)</td><td>54.9 ± 10.2</td><td>65.8 ± 14.2</td><td>< 0.001</td></tr><tr><td>Systemic Hypertension</td><td>32 (49%)</td><td>18 (62%)</td><td>0.22</td></tr><tr><td>Diabetes Mellitus</td><td>12 (18%)</... | |
complex | <table><tr><td></td><td colspan="2">No. of children</td><td>Cumulative incidence</td></tr><tr><td>Year</td><td>Born alive</td><td>With clubfoot</td><td>per thousand (95% CI)</td></tr><tr><td>1991</td><td>62,189</td><td>70</td><td>1.12 (0.9–1.3)</td></tr><tr><td>1992</td><td>68,996</td><td>64</td><td>0.93 (0.8R... | |
complex | <table><tr><td colspan="4">Group session topics</td></tr><tr><td>Session #</td><td>Physical activity</td><td>Nutrition</td><td>Educational incentive</td></tr><tr><td>1</td><td>Overview of healthy nutrition</td><td>Overview of exercise</td><td>Pedometer</td></tr><tr><td>2</td><td>Eating healthy on a budget</td><td>Being... | |
simple | <table><tr><td>Feature</td><td><i>P. fici</i></td></tr><tr><td>Assembly size (Mb)</td><td>52</td></tr><tr><td>Scaffold N50 (Mb)</td><td>4</td></tr><tr><td>Coverage (fold)</td><td>24.5</td></tr><tr><td>GC content (%)</td><td>48.73</td></tr><tr><td>GC exon (%)</td><td>53.56</td></tr><tr><td>GC intron (%)</td><td>44.18</t... | |
simple | <table><tr><td></td><td>Controls (<i>N</i> = 39) (%)</td><td>Cases (<i>N</i> = 123) %</td></tr><tr><td>Stage I</td><td>22 (56)</td><td>55 (45)</td></tr><tr><td>Stage II</td><td>14 (36)</td><td>54 (44)</td></tr><tr><td>Stage III</td><td>3 (8)</td><td>14 (11)</td></tr><tr><td>ER or PR positive/HER2 negative</td><td>33 (8... | |
simple | <table><tr><td>Mutation model</td><td>Sign test</td><td>Standardized differences test</td><td>Wilcoxon test</td></tr><tr><td>IAM</td><td>Hee = 20.49</td><td>T<sub>2 </sub>= 13.196</td><td>P (one tail for H deficiency) 1.000</td></tr><tr><td></td><td>Hd = 0</td><td>P = 0.000</td><td>P (one tail for H excess) 0.000</td><... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.